Medicina alternativa en el tratamiento de la osteoartrosis y artritis reumatoide. Revisión sistemática de la literatura y meta-análisis

improvement was observed with rituximab in SLE-associated hemolytic anemia and thrombocytopenia associated with SLE and antiphospholipid syndrome, who had not responded to first-line therapy. Although LN showed favorable clinical effect and saving allowed dose steroids, prospective studies are required to evaluate utility in patients with LN ≤18.